Axikin Pharmaceuticals
San Diego, US · Founded 2008 · Delaware corporation
Founders & leadership
KB
Kevin B. BaconExecutive
PC
Peter C.M. McWilliamsExecutive
Board
FA
Fred A. MiddletonBoard director
MM
Masaji MatsuokaBoard director
WO
Walter OlesiakBoard director
Reported raises · per SEC filings
Form D private placements$8.5M disclosed across 2 rounds · 2012–2014
▶$6.5MraisedSep 2015 · 7 investors · PharmaceuticalsRule 506(b)
▶$6.5MraisedSep 2015 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Fred A. MiddletonDirector
- Kevin B. BaconExecutive Officer, Director
- Peter C.M. McWilliamsExecutive Officer, Director
- Masaji MatsuokaDirector
- Offering amount
- $11.6M
- Amount sold
- $6.5M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedMar 2012 · 2 investors · PharmaceuticalsRule 506(b)
▶$2MraisedMar 2012 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Fred A. MiddletonDirector
- Walter OlesiakDirector
- Peter C.M. McWilliamsExecutive Officer, Director
- Kevin B. BaconExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $2M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2008
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Axikin Pharmaceuticals raised?
- Axikin Pharmaceuticals has disclosed $8.5M raised across 2 rounds.
- Where is Axikin Pharmaceuticals headquartered?
- Axikin Pharmaceuticals is headquartered in San Diego, US.